Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Tetsu Hayashida

Showing results (71-80 of 84) with videos related to

Pageof 9
Sort By:
Shock (Augusta, Ga.)|March 31, 2010
Protective effect of high-mobility group box 1 blockade on acute liver failure in ratsKiminori Takano, Masahiro Shinoda, Minoru Tanabe, et al.
Breast Cancer (Tokyo, Japan)|May 25, 2025
Axillary surgery in patients with breast cancer with one to three positive micro- or macrometastases in the sentinel lymph nodes: an observational studyShigeru Imoto, Hiroyuki Yasojima, Takeshi Nagashima, et al.
The Oncologist|February 10, 2024
Proton Pump Inhibitors and Cyclin-Dependent Kinase 4/6 Inhibitors in Patients With Breast CancerKaori Takahashi, Ryuji Uozumi, Toru Mukohara, et al.
The Journal of Surgical Research|December 16, 2014
Gene transfer of high-mobility group box 1 box-A domain in a rat acute liver failure modelMasayuki Tanaka, Masahiro Shinoda, Atsushi Takayanagi, et al.
Cancer Science|July 26, 2022
Establishment of a deep-learning system to diagnose BI-RADS4a or higher using breast ultrasound for clinical applicationTetsu Hayashida, Erina Odani, Masayuki Kikuchi, et al.
Scientific Reports|February 6, 2026
Proton-pump inhibitors and palbociclib or abemaciclib in endocrine-sensitive breast cancer treatmentShinya Takada, Kaori Takahashi, Ryuji Uozumi, et al.
Breast Cancer (Tokyo, Japan)|March 17, 2023
Copy number alteration is an independent prognostic biomarker in triple-negative breast cancer patientsMasayuki Nagahashi, YiWei Ling, Chie Toshikawa, et al.
JCO Precision Oncology|June 13, 2020
Actionable gene alterations in an Asian population with triple-negative breast cancerMasayuki Nagahashi, YiWei Ling, Tetsu Hayashida, et al.
International Journal of Clinical Oncology|March 17, 2024
Clinical practice guidelines for molecular tumor marker, 2nd edition review part 2Yoshinori Kikuchi, Hideaki Shimada, Fumiyuki Yamasaki, et al.
The Journal of Histochemistry and Cytochemistry : Official Journal of the Histochemistry Society|April 9, 2019
Magnetically Promoted Rapid Immunofluorescence Staining for Frozen Tissue SectionsTatsuya Onishi, Sachiko Matsuda, Yuki Nakamura, et al.
Pageof 9

Showing results (71-80 of 84) with videos related to

Sort By:
Pageof 9
Shock (Augusta, Ga.)|March 31, 2010
Protective effect of high-mobility group box 1 blockade on acute liver failure in ratsKiminori Takano, Masahiro Shinoda, Minoru Tanabe, et al.
Breast Cancer (Tokyo, Japan)|May 25, 2025
Axillary surgery in patients with breast cancer with one to three positive micro- or macrometastases in the sentinel lymph nodes: an observational studyShigeru Imoto, Hiroyuki Yasojima, Takeshi Nagashima, et al.
The Oncologist|February 10, 2024
Proton Pump Inhibitors and Cyclin-Dependent Kinase 4/6 Inhibitors in Patients With Breast CancerKaori Takahashi, Ryuji Uozumi, Toru Mukohara, et al.
The Journal of Surgical Research|December 16, 2014
Gene transfer of high-mobility group box 1 box-A domain in a rat acute liver failure modelMasayuki Tanaka, Masahiro Shinoda, Atsushi Takayanagi, et al.
Cancer Science|July 26, 2022
Establishment of a deep-learning system to diagnose BI-RADS4a or higher using breast ultrasound for clinical applicationTetsu Hayashida, Erina Odani, Masayuki Kikuchi, et al.
Scientific Reports|February 6, 2026
Proton-pump inhibitors and palbociclib or abemaciclib in endocrine-sensitive breast cancer treatmentShinya Takada, Kaori Takahashi, Ryuji Uozumi, et al.
Breast Cancer (Tokyo, Japan)|March 17, 2023
Copy number alteration is an independent prognostic biomarker in triple-negative breast cancer patientsMasayuki Nagahashi, YiWei Ling, Chie Toshikawa, et al.
JCO Precision Oncology|June 13, 2020
Actionable gene alterations in an Asian population with triple-negative breast cancerMasayuki Nagahashi, YiWei Ling, Tetsu Hayashida, et al.
International Journal of Clinical Oncology|March 17, 2024
Clinical practice guidelines for molecular tumor marker, 2nd edition review part 2Yoshinori Kikuchi, Hideaki Shimada, Fumiyuki Yamasaki, et al.
The Journal of Histochemistry and Cytochemistry : Official Journal of the Histochemistry Society|April 9, 2019
Magnetically Promoted Rapid Immunofluorescence Staining for Frozen Tissue SectionsTatsuya Onishi, Sachiko Matsuda, Yuki Nakamura, et al.
Pageof 9